PCS-2023: 3E0Q Introduction, Cranial Cavity and Brain

PCS-2023 > 3 > 3E > 3E0 > 3E0Q

3E0	Physiological Systems and Anatomical Regions, Introduction
	Info:	Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
3E0Q	Introduction, Cranial Cavity and Brain
3E0Q0	Open
3E0Q00	Antineoplastic
3E0Q004	Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Open Approach
3E0Q005	Introduction of Other Antineoplastic into Cranial Cavity and Brain, Open Approach
3E0Q00M	Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approach
3E0Q02	Anti-infective
3E0Q028	Introduction of Oxazolidinones into Cranial Cavity and Brain, Open Approach
3E0Q029	Introduction of Other Anti-infective into Cranial Cavity and Brain, Open Approach
3E0Q03	Anti-inflammatory
3E0Q03Z	Introduction of Anti-inflammatory into Cranial Cavity and Brain, Open Approach
3E0Q06	Nutritional Substance
3E0Q06Z	Introduction of Nutritional Substance into Cranial Cavity and Brain, Open Approach
3E0Q07	Electrolytic and Water Balance Substance
3E0Q07Z	Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Open Approach
3E0Q0A	Stem Cells, Embryonic
3E0Q0AZ	Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Open Approach
3E0Q0B	Anesthetic Agent
3E0Q0BZ	Introduction of Anesthetic Agent into Cranial Cavity and Brain, Open Approach
3E0Q0H	Radioactive Substance
3E0Q0HZ	Introduction of Radioactive Substance into Cranial Cavity and Brain, Open Approach
3E0Q0K	Other Diagnostic Substance
3E0Q0KZ	Introduction of Other Diagnostic Substance into Cranial Cavity and Brain, Open Approach
3E0Q0N	Analgesics, Hypnotics, Sedatives
3E0Q0NZ	Introduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Open Approach
3E0Q0T	Destructive Agent
3E0Q0TZ	Introduction of Destructive Agent into Cranial Cavity and Brain, Open Approach
3E0Q0E	Stem Cells, Somatic
3E0Q0E0	Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach
3E0Q0E1	Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach
3E0Q0G	Other Therapeutic Substance
3E0Q0GC	Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Open Approach
3E0Q0S	Gas
3E0Q0SF	Introduction of Other Gas into Cranial Cavity and Brain, Open Approach
3E0Q3	Percutaneous
3E0Q30	Antineoplastic
3E0Q304	Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Percutaneous Approach
3E0Q305	Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach
3E0Q30M	Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach
3E0Q32	Anti-infective
3E0Q328	Introduction of Oxazolidinones into Cranial Cavity and Brain, Percutaneous Approach
3E0Q329	Introduction of Other Anti-infective into Cranial Cavity and Brain, Percutaneous Approach
3E0Q33	Anti-inflammatory
3E0Q33Z	Introduction of Anti-inflammatory into Cranial Cavity and Brain, Percutaneous Approach
3E0Q36	Nutritional Substance
3E0Q36Z	Introduction of Nutritional Substance into Cranial Cavity and Brain, Percutaneous Approach
3E0Q37	Electrolytic and Water Balance Substance
3E0Q37Z	Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Percutaneous Approach
3E0Q3A	Stem Cells, Embryonic
3E0Q3AZ	Introduction of Embryonic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach
3E0Q3B	Anesthetic Agent
3E0Q3BZ	Introduction of Anesthetic Agent into Cranial Cavity and Brain, Percutaneous Approach
3E0Q3H	Radioactive Substance
3E0Q3HZ	Introduction of Radioactive Substance into Cranial Cavity and Brain, Percutaneous Approach
3E0Q3K	Other Diagnostic Substance
3E0Q3KZ	Introduction of Other Diagnostic Substance into Cranial Cavity and Brain, Percutaneous Approach
3E0Q3N	Analgesics, Hypnotics, Sedatives
3E0Q3NZ	Introduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Percutaneous Approach
3E0Q3T	Destructive Agent
3E0Q3TZ	Introduction of Destructive Agent into Cranial Cavity and Brain, Percutaneous Approach
3E0Q3E	Stem Cells, Somatic
3E0Q3E0	Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach
3E0Q3E1	Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach
3E0Q3G	Other Therapeutic Substance
3E0Q3GC	Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Percutaneous Approach
3E0Q3S	Gas
3E0Q3SF	Introduction of Other Gas into Cranial Cavity and Brain, Percutaneous Approach
3E0Q7	Via Natural or Artificial Opening
3E0Q70	Antineoplastic
3E0Q704	Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Via Natural or Artificial Opening
3E0Q705	Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening
3E0Q70M	Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening
3E0Q7S	Gas
3E0Q7SF	Introduction of Other Gas into Cranial Cavity and Brain, Via Natural or Artificial Opening

and

Physiological Systems and Anatomical Regions, Introduction

Introduction, Cranial Cavity and Brain